We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Hepatitis C Infection May Increase Cardiovascular Risk

By LabMedica International staff writers
Posted on 30 Aug 2015
Print article
Image: Scanning electron micrograph of Hepatitis C viruses (Photo courtesy of Cardiff University).
Image: Scanning electron micrograph of Hepatitis C viruses (Photo courtesy of Cardiff University).
People infected with the Hepatitis C virus (HCV) are at risk for liver damage, but the infection may also lead to cardiovascular damage.

A recent study found that participants chronically infected with hepatitis C were more likely to harbor abnormal fat-and-calcium plaques inside their arteries, a condition known as atherosclerosis and a common forerunner of heart attacks and strokes.

Scientists at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) and their colleagues assessed 994 men 40 to 70 years old without overt heart disease who were followed across several institutions in Baltimore, Washington DC, Pittsburgh, Los Angeles, and Chicago. Of the 994, 613 were infected with human immunodeficiency virus (HIV), 70 were infected with both viruses and 17 were only infected with hepatitis C. Participants underwent cardiac computed tomography (CT) scans to detect and measure the amount of fat and calcium deposits inside the vessels of their hearts.

Study participants who had higher levels of circulating HCV in their blood were 50% more likely to have clogged arteries, compared with men without hepatitis C. Higher virus levels in the blood signal that the infection is not well controlled by drugs or the immune system. Poorly controlled infection, the investigators added, may lead to more inflammation throughout the body, which can fuel blood vessel damage and thus contribute to heart disease. Those infected with hepatitis C, regardless of HIV status, had, on average, 30% more disease-fueling calcified plaque in their arteries, the main driver of heart attack and stroke risk. People infected with either HIV or hepatitis C, on average, had 42% more non-calcified fatty buildup, a type of plaque believed to confer the greatest cardiac risk.

Eric Seaberg, PhD, assistant professor of epidemiology, and lead investigator, said, “We have strong reason to believe that infection with hepatitis C fuels cardiovascular disease, independent of HIV and sets the stage for subsequent cardiovascular trouble. We believe our findings are relevant to anyone infected with hepatitis C regardless of HIV status.” The authors concluded that chronic HCV infection is associated with subclinical cardiovascular disease, suggesting that HCV-infected individuals warrant vigilant cardiovascular risk assessments. The study was published on July 27, 2015, in the Journal of Infectious Diseases.

Related Links:

Johns Hopkins Bloomberg School of Public Health


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.